Crystallographic and electrophilic fragment screening of the SARS-CoV-2 main protease

A. Douangamath, D. Fearon, Paul Gehrtz, +31

Nature Communications

Rapid Covalent-Probe Discovery by Electrophile-Fragment Screening

Efrat Resnick, A.R. Bradley, Jinrui Gan, +31

Journal of the American Chemical Society

Chemical BiologySelective ProbesBiochemistryNatural SciencesSelectivity Challenge +13

Open science discovery of potent noncovalent SARS-CoV-2 main protease inhibitors

Melissa L. Boby, D. Fearon, Matteo P. Ferla, +208

Science

Sulfopin is a covalent inhibitor of Pin1 that blocks Myc-driven tumors in vivo

Christian Dubiella, Benika J. Pinch, Kazuhiro Koikawa, +41

Nature Chemical Biology

Covalent InhibitorOncologyMalignant DiseaseMedicineCancer Biology +7

Tunable Methacrylamides for Covalent Ligand Directed Release Chemistry

Rambabu Reddi, Efrat Resnick, Adi Rogel, +9

Journal of the American Chemical Society

An automatic pipeline for the design of irreversible derivatives identifies a potent SARS-CoV-2 Mpro inhibitor

Daniel Zaidman, Paul Gehrtz, Mihajlo Filep, +14

Cell chemical biology

Irreversible DerivativesMedicineNatural SciencesAntiviral Drug DevelopmentRational Drug Design +7

Site-Specific Labeling of Endogenous Proteins Using CoLDR Chemistry

Rambabu Reddi, Adi Rogel, Efrat Resnick, +6

Journal of the American Chemical Society

Crystallographic and electrophilic fragment screening of the SARS-CoV-2 main protease

A. Douangamath, D. Fearon, Paul Gehrtz, +31

Summary Covid-19Protein AssemblyCombined Mass SpectrometryMolecular BiologyAntiviral Drug +15

Turning high-throughput structural biology into predictive inhibitor design

Kadi L. Saar, William McCorkindale, D. Fearon, +207

Proceedings of the National Academy of Sciences

Rapid covalent-probe discovery by electrophile fragment screening

Efrat Resnick, A.R. Bradley, Jinrui Gan, +26

Molecular RecognitionSelective ProbesBiochemistryNatural SciencesSelectivity Challenge +12